COMMUNIQUÉS West-GlobeNewswire

-
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with IXICO for the Transformative Bio-Hermes-002 Study
22/07/2025 -
Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors
22/07/2025 -
Aeroflow Health Announces Virtual Nutrition Services are Now Available to Cigna Patients Across the Country
22/07/2025 -
Solera Health Expands Capabilities in Insights Through Unique Machine Learning Predictive Models – Driving Improvements in Care Outcomes and Costs
22/07/2025 -
Kraken and Windtree Therapeutics Announce Strategic Partnership for BNB Custody, Trading, and OTC Services
22/07/2025 -
Betterguards Forms Strategic Alliance with NBATA to Accelerate Injury Prevention & Recovery Innovation
22/07/2025 -
DoseSpot Collaborates with Amazon Pharmacy to Improve Prescription Medication Pricing Transparency, Give Patients More Fulfillment Options
22/07/2025 -
American Gene Technologies Announces Promising Results from AGT103-T HIV Functional Cure Program Presented as Late-Breaker at International AIDS Society 2025
22/07/2025 -
100,000 Customers Choose Hemp Hop As Their Go-To Place to Buy THCa Flower
22/07/2025 -
HMNC Brain Health and Spruce Biosciences Announce First Patient Dosed in Phase 2 TAMARIND Trial For Major Depressive Disorder
22/07/2025 -
Jyong Biotech Ltd. Rings Nasdaq Bell and Participates at the BIO 2025 International Convention
22/07/2025 -
Instinct EMR Partners with Arista Advanced Pet Care’s New Specialty and Emergency Hospitals
22/07/2025 -
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
22/07/2025 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 29 - 2025
22/07/2025 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 29 - 2025
22/07/2025 -
Arch Biopartners Announces Start of Patient Recruitment in Phase II PONTIAK Trial Targeting Drug-Toxin-Related Acute Kidney Injury (AKI)
22/07/2025 -
BridgeBio to Host Second Quarter 2025 Financial Results Conference Call on Tuesday, August 5, 2025 at 4:30 pm ET
22/07/2025 -
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
22/07/2025 -
Reunion Neuroscience Announces Publication of RE104 Phase 1 Data in The Journal of Clinical Psychopharmacology
22/07/2025
Pages